alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 13,051–13,075 of 27,380 studies, newest first · page 523 of 1096.

March 2019 25

  1. 2019-03-06

    ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes

    ✓ Peer-reviewed Tau biomarkers Neurology

    Key finding: Pooling data across 4 cohort studies, 814 cognitively normal participants (mean baseline age = 59.6 years) were classified into 8 ATN groups using baseline CSF levels of β-amyloid 1-42 as a measure of amyloid (A), phosphorylated tau 181 as a measure of tau (T), and total tau as a measure of neurodegeneration (N). +3 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2019-03-06

    Health effects of particulate matter air pollution in underground railway systems - a critical review of the evidence

    ✓ Peer-reviewed Disparities Particle and fibre toxicology

    Key finding: There is little direct evidence that underground railway particulate matter exposure is more harmful than ambient particulate matter exposure. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2019-03-05

    A review of the possible associations between ambient PM2.5 exposures and the development of Alzheimer's disease

    ✓ Peer-reviewed Risk factors Ecotoxicology and environmental safety

    Key finding: PM2.5 particles in air pollution have been widely considered associated with respiratory and cardiovascular diseases. +1 more finding

    Full summary, score breakdown and related studies → Original source

  4. 2019-03-05

    Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice

    ✓ Peer-reviewed TREM2 and immune genetics Molecular neurodegeneration

    Key finding: Microglia are the principal innate immune defense cells of the centeral nervous system (CNS) and the target of the human immunodeficiency virus type one (HIV-1). +3 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2019-03-05

    Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals

    ✓ Peer-reviewed Digital health tools Scientific reports

    Key finding: Our findings suggest that dCDT is a suitable screening tool to identify early cognitive dysfunction.

    Full summary, score breakdown and related studies → Original source

  6. 2019-03-05

    Effects of a moderate-intensity aerobic exercise programme on the cognitive function and quality of life of community-dwelling elderly people with mild cognitive impairment: A randomised controlled trial

    ✓ Peer-reviewed Prevention and risk International journal of nursing studies

    Key finding: Whether the cognitive benefits of physical exercise can improve the overall well-being of this group remains unknown. +1 more finding

    Full summary, score breakdown and related studies → Original source

  7. 2019-03-04

    The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Clinica chimica acta; international journal of clinical chemistry

    Key finding: Our study showed that the use of CSF Aβ42/Aβ40 could significantly improve the routine diagnostic work up of AD.

    Full summary, score breakdown and related studies → Original source

  8. 2019-03-04

    Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System

    ✓ Peer-reviewed Biomarkers Frontiers in immunology

    Key finding: There have been a few recent clinical trials of available anti-complement drugs in CNS diseases associated with BBB impairment, for example the use of the anti-C5 monoclonal antibody (mAb) eculizumab in NMO, but for most CNS diseases there have been no human trials of anti-complement therapies.

    Full summary, score breakdown and related studies → Original source

  9. 2019-03-04

    Physical and cognitive training are able to prevent recognition memory deficits related to amyloid beta neurotoxicity

    ✓ Peer-reviewed Prevention trials Behavioural brain research

    Key finding: Considering that physical exercise neuroprotective effects on prevention of cognitive deficits are well elucidate, it is important clarify the effects of cognitive training, and verify if they are similar or comparable to those observed for physical exercise. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2019-03-04

    Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study

    ✓ Peer-reviewed Long-term cohort studies PloS one

    Key finding: Fibroblast growth factor 23 is an emerging vascular biomarker, recently associated with cerebral small vessel disease and poor cognition in patients on dialysis. +3 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2019-03-04

    DIVE: A spatiotemporal progression model of brain pathology in neurodegenerative disorders

    ✓ Peer-reviewed Long-term cohort studies NeuroImage

    Key finding: Such models are unable to recover fine details of atrophy patterns; they tend to impose an assumption of strong spatial correlation within each ROI and no correlation among ROIs. +3 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2019-03-04

    Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease

    ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The four emerging CSF biomarkers were significantly elevated in the mutation carriers (n = 235) versus noncarriers (n = 145). +3 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2019-03-02

    What the NHS Long-Term Plan means for dementia care

    ✓ Peer-reviewed Health systems and care delivery Nursing and Residential Care

    Key finding: In January, the NHS presented its long-awaited plan to transform care over the next 10 years. +1 more finding

    Full summary, score breakdown and related studies → Original source

  14. 2019-03-02

    Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease

    ✓ Peer-reviewed Biomarkers Molecular neurobiology

    Key finding: Our aim is to find whether RBC concentrations of α-syn and its heterocomplexes (i.e., α-syn/Aβ and α-syn/tau) were different in AD patients compared with healthy controls (HC). +1 more finding

    Full summary, score breakdown and related studies → Original source

  15. 2019-03-01

    Presenilins and γ-Secretase in Membrane Proteostasis

    ✓ Peer-reviewed Disease mechanisms Cells

    Key finding: The two homologous proteins PS1 and PS2 represent the catalytic subunits of distinct γ-secretase complexes that mediate a variety of cellular processes, including membrane protein metabolism, signal transduction, and cell differentiation. +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2019-03 month only

    Dementia prevention and reserve against neurodegenerative disease

    ✓ Peer-reviewed Risk factors Dialogues in clinical neuroscience

    Key finding: The concept of reserve was developed based on the observation that certain individual characteristics, such as life experiences, lifestyles, and neurobiological parameters, are associated with a higher resilience against neurodegeneration and its symptoms.

    Full summary, score breakdown and related studies → Original source

  17. 2019-03 month only

    Hearing interventions to prevent dementia

    ✓ Peer-reviewed Risk factors HNO

    Key finding: Seven studies of hearing interventions with cognitive outcomes assessed over longer than 3 years are reviewed. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2019-03-01

    Effectiveness of Implementing a Collaborative Chronic Care Model for Clinician Teams on Patient Outcomes and Health Status in Mental Health: A Randomized Clinical Trial

    ✓ Peer-reviewed Digital health tools JAMA network open

    Key finding: Implementation facilitation that engages clinicians under typical practice conditions can enhance evidence-based team processes; its effect on self-reported overall population health status was negligible, although health status improved for individuals with complex conditions and hospitalization rate declined. +4 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2019-03-01

    Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study

    ✓ Peer-reviewed Digital health tools Drugs & aging

    Key finding: The same daily ACB score was associated with a different degree of risk, depending on the ACB ratings of the individual drugs comprising the score. +4 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2019-03-01

    Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases

    ✓ Peer-reviewed Drug development CNS drugs

    Key finding: We review studies revealing the neuroprotective actions of GLP-1 analogues in pre-clinical models of AD and PD and promising results from recent clinical trials.

    Full summary, score breakdown and related studies → Original source

  21. 2019-03-01

    A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward

    ✓ Peer-reviewed Genetics Neuron

    Key finding: This view is clouded, however, by lingering uncertainty over how to treat the quasi "monogenic" role of apolipoprotein E (APOE). +4 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2019-03-01

    Plasma tau/amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease

    ✓ Peer-reviewed Hippocampus size on brain scans Brain : a journal of neurology

    Key finding: We found significant correlations of plasma p-tau, t-tau, p-tau/amyloid-β1-42, and t-tau/amyloid-β1-42 with brain tau deposition in cross-sectional and longitudinal manners. +2 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2019-03-01

    Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis

    ✓ Peer-reviewed Clinical safety JAMA network open

    Key finding: Seventeen studies (5373 patients) were included. +4 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2019-03-01

    Essential oils and functional herbs for healthy aging

    ✓ Peer-reviewed Prevention trials Neural regeneration research

    Key finding: It has been shown that aromatherapy with essential oils from the mint family can improve cognitive performance in Alzheimer's disease patients. +1 more finding

    Full summary, score breakdown and related studies → Original source

  25. 2019-03-01

    The Role of Nutrition for the Aging Population: Implications for Cognition and Alzheimer's Disease

    ✓ Peer-reviewed Prevention trials Annual review of food science and technology

    Key finding: Improved life expectancy worldwide has resulted in a significant increase in age-related diseases. +2 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →